HBIO Annual Revenue
$112.25 M
-$1.08 M-0.96%
31 December 2023
Summary:
As of January 23, 2025, HBIO annual revenue is $112.25 million, with the most recent change of -$1.08 million (-0.96%) on December 31, 2023. During the last 3 years, it has risen by +$10.15 million (+9.94%). HBIO annual revenue is now -7.06% below its all-time high of $120.77 million, reached on December 31, 2018.HBIO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HBIO Quarterly Revenue
$21.97 M
-$1.13 M-4.88%
30 September 2024
Summary:
As of January 23, 2025, HBIO quarterly revenue is $21.97 million, with the most recent change of -$1.13 million (-4.88%) on September 30, 2024. Over the past year, it has dropped by -$3.39 million (-13.38%). HBIO quarterly revenue is now -35.11% below its all-time high of $33.86 million, reached on December 31, 2018.HBIO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HBIO TTM Revenue
$97.73 M
-$3.39 M-3.36%
30 September 2024
Summary:
As of January 23, 2025, HBIO TTM revenue is $97.73 million, with the most recent change of -$3.39 million (-3.36%) on September 30, 2024. Over the past year, it has dropped by -$14.79 million (-13.15%). HBIO TTM revenue is now -20.03% below its all-time high of $122.22 million, reached on March 31, 2019.HBIO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HBIO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.0% | -13.4% | -13.2% |
| 3 y3 years | +9.9% | -25.9% | -16.4% |
| 5 y5 years | -7.1% | -19.9% | -15.9% |
HBIO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.6% | at low | -33.5% | at low | -19.0% | at low |
| 5 y | 5-year | -5.6% | +9.9% | -33.5% | at low | -19.0% | at low |
| alltime | all time | -7.1% | +823.6% | -35.1% | +198.7% | -20.0% | +1228.5% |
Harvard Bioscience Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $21.97 M(-4.9%) | $97.73 M(-3.4%) |
| June 2024 | - | $23.10 M(-5.8%) | $101.13 M(-5.3%) |
| Mar 2024 | - | $24.51 M(-12.9%) | $106.79 M(-4.9%) |
| Dec 2023 | $112.25 M(-1.0%) | $28.15 M(+11.0%) | $112.25 M(-0.2%) |
| Sept 2023 | - | $25.36 M(-11.8%) | $112.52 M(-1.4%) |
| June 2023 | - | $28.76 M(-4.1%) | $114.08 M(-0.4%) |
| Mar 2023 | - | $29.98 M(+5.4%) | $114.53 M(+1.1%) |
| Dec 2022 | $113.33 M(-4.7%) | $28.43 M(+5.6%) | $113.33 M(-3.9%) |
| Sept 2022 | - | $26.92 M(-7.8%) | $117.96 M(-2.3%) |
| June 2022 | - | $29.21 M(+1.5%) | $120.70 M(+0.0%) |
| Mar 2022 | - | $28.78 M(-12.9%) | $120.69 M(+1.5%) |
| Dec 2021 | $118.90 M(+16.5%) | $33.05 M(+11.4%) | $118.90 M(+1.8%) |
| Sept 2021 | - | $29.66 M(+1.6%) | $116.83 M(+5.1%) |
| June 2021 | - | $29.20 M(+8.2%) | $111.21 M(+5.6%) |
| Mar 2021 | - | $26.99 M(-12.9%) | $105.32 M(+3.2%) |
| Dec 2020 | $102.10 M(-12.1%) | $30.98 M(+28.9%) | $102.10 M(+0.0%) |
| Sept 2020 | - | $24.04 M(+3.1%) | $102.09 M(-3.2%) |
| June 2020 | - | $23.31 M(-1.9%) | $105.47 M(-5.6%) |
| Mar 2020 | - | $23.77 M(-23.3%) | $111.75 M(-3.8%) |
| Dec 2019 | $116.18 M(-3.8%) | $30.97 M(+13.0%) | $116.18 M(-2.4%) |
| Sept 2019 | - | $27.42 M(-7.3%) | $119.06 M(-1.0%) |
| June 2019 | - | $29.58 M(+4.9%) | $120.28 M(-1.6%) |
| Mar 2019 | - | $28.20 M(-16.7%) | $122.22 M(+1.2%) |
| Dec 2018 | $120.77 M(+56.0%) | $33.86 M(+18.2%) | $120.77 M(+11.2%) |
| Sept 2018 | - | $28.64 M(-9.2%) | $108.56 M(+10.1%) |
| June 2018 | - | $31.52 M(+17.8%) | $98.64 M(+14.6%) |
| Mar 2018 | - | $26.76 M(+23.6%) | $86.08 M(+11.2%) |
| Dec 2017 | $77.41 M(-25.9%) | $21.65 M(+15.6%) | $77.41 M(-5.8%) |
| Sept 2017 | - | $18.72 M(-1.3%) | $82.18 M(-7.1%) |
| June 2017 | - | $18.96 M(+4.8%) | $88.47 M(-7.5%) |
| Mar 2017 | - | $18.09 M(-31.5%) | $95.64 M(-8.5%) |
| Dec 2016 | $104.52 M(-3.8%) | $26.41 M(+5.6%) | $104.52 M(-1.8%) |
| Sept 2016 | - | $25.01 M(-4.3%) | $106.48 M(-0.7%) |
| June 2016 | - | $26.14 M(-3.1%) | $107.20 M(-2.4%) |
| Mar 2016 | - | $26.96 M(-5.0%) | $109.86 M(+1.1%) |
| Dec 2015 | $108.66 M(+0.0%) | $28.37 M(+10.3%) | $108.66 M(-1.8%) |
| Sept 2015 | - | $25.73 M(-10.7%) | $110.66 M(+0.3%) |
| June 2015 | - | $28.80 M(+11.8%) | $110.38 M(+1.7%) |
| Mar 2015 | - | $25.76 M(-15.2%) | $108.53 M(-0.1%) |
| Dec 2014 | $108.66 M(+3.3%) | $30.36 M(+19.3%) | $108.66 M(+2.4%) |
| Sept 2014 | - | $25.45 M(-5.6%) | $106.15 M(+0.3%) |
| June 2014 | - | $26.96 M(+4.1%) | $105.84 M(+0.8%) |
| Mar 2014 | - | $25.89 M(-7.0%) | $104.98 M(-0.2%) |
| Dec 2013 | $105.17 M(-5.4%) | $27.85 M(+10.8%) | $105.17 M(-0.4%) |
| Sept 2013 | - | $25.14 M(-3.7%) | $105.57 M(-0.9%) |
| June 2013 | - | $26.09 M(+0.0%) | $106.53 M(-2.2%) |
| Mar 2013 | - | $26.09 M(-7.7%) | $108.94 M(-2.0%) |
| Dec 2012 | $111.17 M | $28.25 M(+8.2%) | $111.17 M(-0.7%) |
| Sept 2012 | - | $26.10 M(-8.4%) | $111.95 M(-0.2%) |
| June 2012 | - | $28.50 M(+0.6%) | $112.23 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $28.32 M(-2.4%) | $110.87 M(+1.8%) |
| Dec 2011 | $108.86 M(+0.6%) | $29.03 M(+10.0%) | $108.86 M(-0.5%) |
| Sept 2011 | - | $26.38 M(-2.8%) | $109.36 M(-0.1%) |
| June 2011 | - | $27.14 M(+3.2%) | $109.43 M(+1.1%) |
| Mar 2011 | - | $26.31 M(-10.9%) | $108.19 M(+0.0%) |
| Dec 2010 | $108.18 M(+26.1%) | $29.52 M(+11.6%) | $108.18 M(+1.8%) |
| Sept 2010 | - | $26.45 M(+2.1%) | $106.31 M(+5.4%) |
| June 2010 | - | $25.91 M(-1.5%) | $100.86 M(+8.4%) |
| Mar 2010 | - | $26.30 M(-4.9%) | $93.00 M(+8.4%) |
| Dec 2009 | $85.77 M(-2.6%) | $27.65 M(+31.7%) | $85.77 M(+5.7%) |
| Sept 2009 | - | $21.00 M(+16.3%) | $81.17 M(+1.3%) |
| June 2009 | - | $18.05 M(-5.4%) | $80.16 M(-5.9%) |
| Mar 2009 | - | $19.07 M(-17.3%) | $85.16 M(-3.3%) |
| Dec 2008 | $88.05 M(+5.6%) | $23.05 M(+15.3%) | $88.05 M(-1.6%) |
| Sept 2008 | - | $19.99 M(-13.3%) | $89.53 M(+0.7%) |
| June 2008 | - | $23.05 M(+5.0%) | $88.89 M(+3.1%) |
| Mar 2008 | - | $21.96 M(-10.5%) | $86.25 M(+3.4%) |
| Dec 2007 | $83.41 M(+9.5%) | $24.53 M(+26.7%) | $83.41 M(+3.5%) |
| Sept 2007 | - | $19.35 M(-5.2%) | $80.56 M(+0.5%) |
| June 2007 | - | $20.41 M(+6.8%) | $80.15 M(+2.9%) |
| Mar 2007 | - | $19.11 M(-11.8%) | $77.93 M(+2.3%) |
| Dec 2006 | $76.18 M(+13.0%) | $21.68 M(+14.5%) | $76.18 M(+5.3%) |
| Sept 2006 | - | $18.94 M(+4.1%) | $72.34 M(+2.5%) |
| June 2006 | - | $18.19 M(+4.7%) | $70.58 M(+2.8%) |
| Mar 2006 | - | $17.37 M(-2.6%) | $68.67 M(+1.8%) |
| Dec 2005 | $67.43 M(+4.1%) | $17.84 M(+3.8%) | $67.43 M(+0.6%) |
| Sept 2005 | - | $17.18 M(+5.5%) | $67.02 M(+1.0%) |
| June 2005 | - | $16.28 M(+0.9%) | $66.34 M(-8.5%) |
| Mar 2005 | - | $16.14 M(-7.4%) | $72.53 M(-7.7%) |
| Dec 2004 | $64.75 M(-25.7%) | $17.43 M(+5.6%) | $78.56 M(-7.9%) |
| Sept 2004 | - | $16.51 M(-26.5%) | $85.34 M(-5.1%) |
| June 2004 | - | $22.46 M(+1.3%) | $89.94 M(+0.1%) |
| Mar 2004 | - | $22.16 M(-8.4%) | $89.83 M(+3.1%) |
| Dec 2003 | $87.14 M(+51.9%) | $24.21 M(+14.7%) | $87.14 M(+6.5%) |
| Sept 2003 | - | $21.11 M(-5.6%) | $81.83 M(+11.3%) |
| June 2003 | - | $22.35 M(+14.8%) | $73.51 M(+13.3%) |
| Mar 2003 | - | $19.47 M(+3.1%) | $64.89 M(+13.1%) |
| Dec 2002 | $57.38 M(+40.4%) | $18.89 M(+47.6%) | $57.38 M(+13.9%) |
| Sept 2002 | - | $12.80 M(-6.8%) | $50.40 M(+4.5%) |
| June 2002 | - | $13.73 M(+14.8%) | $48.24 M(+9.1%) |
| Mar 2002 | - | $11.96 M(+0.5%) | $44.22 M(+8.2%) |
| Dec 2001 | $40.87 M(+33.7%) | $11.91 M(+11.9%) | $40.87 M(+9.1%) |
| Sept 2001 | - | $10.64 M(+9.6%) | $37.47 M(+9.6%) |
| June 2001 | - | $9.71 M(+12.8%) | $34.18 M(+7.4%) |
| Mar 2001 | - | $8.61 M(+1.2%) | $31.83 M(+4.1%) |
| Dec 2000 | $30.57 M(+16.8%) | $8.51 M(+15.6%) | $30.57 M(+38.5%) |
| Sept 2000 | - | $7.36 M(0.0%) | $22.07 M(+50.0%) |
| June 2000 | - | $7.36 M(0.0%) | $14.71 M(+100.0%) |
| Mar 2000 | - | $7.36 M | $7.36 M |
| Dec 1999 | $26.18 M(+115.4%) | - | - |
| Dec 1998 | $12.15 M | - | - |
FAQ
- What is Harvard Bioscience annual revenue?
- What is the all time high annual revenue for Harvard Bioscience?
- What is Harvard Bioscience annual revenue year-on-year change?
- What is Harvard Bioscience quarterly revenue?
- What is the all time high quarterly revenue for Harvard Bioscience?
- What is Harvard Bioscience quarterly revenue year-on-year change?
- What is Harvard Bioscience TTM revenue?
- What is the all time high TTM revenue for Harvard Bioscience?
- What is Harvard Bioscience TTM revenue year-on-year change?
What is Harvard Bioscience annual revenue?
The current annual revenue of HBIO is $112.25 M
What is the all time high annual revenue for Harvard Bioscience?
Harvard Bioscience all-time high annual revenue is $120.77 M
What is Harvard Bioscience annual revenue year-on-year change?
Over the past year, HBIO annual revenue has changed by -$1.08 M (-0.96%)
What is Harvard Bioscience quarterly revenue?
The current quarterly revenue of HBIO is $21.97 M
What is the all time high quarterly revenue for Harvard Bioscience?
Harvard Bioscience all-time high quarterly revenue is $33.86 M
What is Harvard Bioscience quarterly revenue year-on-year change?
Over the past year, HBIO quarterly revenue has changed by -$3.39 M (-13.38%)
What is Harvard Bioscience TTM revenue?
The current TTM revenue of HBIO is $97.73 M
What is the all time high TTM revenue for Harvard Bioscience?
Harvard Bioscience all-time high TTM revenue is $122.22 M
What is Harvard Bioscience TTM revenue year-on-year change?
Over the past year, HBIO TTM revenue has changed by -$14.79 M (-13.15%)